Home / Press Releases / IBM, FDA to Study Blockchain Technology Application for Health Data

IBM, FDA to Study Blockchain Technology Application for Health Data

TYSONS CORNER, VA, Jan. 13, 2017 — IBM‘s (NYSE: IBM) Watson Health unit has entered into a research initiative with the U.S. Food and Drug Administration in an effort to explore blockchain technology application for health data, ExecutiveBiz reported Thursday.

The company said Wednesday it will work with the agency to study oncology-related data and the secure exchange of owner-mediated information from electronic medical records, clinical trials and mobile devices, wearables and the Internet of Things.

About Executive Mosaic: Founded in 2002, Executive Mosaic is a leadership organization and media company. Executive Mosaic offers highly coveted executive events, breaking business news on the Government Contracting industry, and delivers robust and reliable content through seven influential websites and four consequential E-newswires. Headquarters are located in Tysons Corner, VA. www.executivemosaic.com

Contact:
David Smith
(703) 226-7002
david.smith@executivemosaic.com

Check Also

Iridium’s Scott Scheimreif: Demand to Grow for Small-Form-Factor Broadband Antennas

TYSONS CORNER, VA, June 22, 2018 — Scott Scheimreif, executive vice president of government programs …

CACI Earns AWS ‘Premier’ Consulting Partner Status

TYSONS CORNER, VA, June 22, 2018 — CACI International (NYSE: CACI) has been named a “premier” …